This week in Australian life sciences: a $1.6B digital health acquisition, global momentum in cell and gene therapy, AI in regulatory affairs, and registrations opening for the 2026 ARCS Annual Conference.

In this short episode, Tim Boyle breaks down the top 3 stories shaping biotech, medtech, clinical trials and therapeutic product commercialisation across Australia and the Asia-Pacific.

Fast insights. Big implications. Stay ahead of the sector.

#lifesciences #biotech #medtech #clinicaltrials #regulatoryaffairs